Friday 19 November 2021
Ottawa – (AA):
Today, Friday, Health Canada approved the use of the Pfizer company’s anti-coronavirus vaccine for children aged 5 to 11 years.
The vaccine requires two doses (10 micrograms) for children aged 5 to 11 years, which is one-third of the dose for adults. The National Immunization Advisory Committee recommends that these two doses be separated by eight weeks, and the committee also recommends that children not receive another vaccine, such as the influenza vaccine, 14 days before or after the (Pfizer) vaccine.
“This is very good news for adults and children alike,” Dr. Supriya Sharma, Senior Medical Adviser to Health Canada, said at a press conference. “It provides another tool to protect Canadians and to comfort many parents. It will help restore a degree of normalcy to children’s lives,” she said. This allows them to more safely do the things they have missed in the last 20 months.”
Health Canada said – in a press release – “After a comprehensive and independent scientific review of the evidence, the authority has determined that the benefits of this vaccine for children aged 5 to 11 years outweigh the risks.”